A H Anis
Overview
Explore the profile of A H Anis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
722
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holowachuk S, Zhang W, Gandhi S, Anis A, Potts J, Harris K
Pediatr Cardiol
. 2018 Sep;
40(1):138-146.
PMID: 30203291
The clinical benefit of early extubation following congenital heart surgery has been demonstrated; however, its effect on resource utilization has not been rigorously evaluated. We sought to determine the cost...
2.
Woolcott J, Khan K, Mitrovic S, Anis A, Marra C
Osteoporos Int
. 2011 Sep;
23(5):1513-9.
PMID: 21892675
Unlabelled: We prospectively collected data on elderly fallers to estimate the total cost of a fall requiring an Emergency Department presentation. Using data collected on 102 falls, we found the...
3.
Kopec J, Sayre E, Flanagan W, Fines P, Cibere J, Rahman M, et al.
Osteoarthritis Cartilage
. 2009 Nov;
18(3):303-11.
PMID: 19879999
Objectives: The purpose of the study was to develop a population-based simulation model of osteoarthritis (OA) in Canada that can be used to quantify the future health and economic burden...
4.
Anis A, Zhang W, Bansback N, Guh D, Amarsi Z, Birmingham C
Obes Rev
. 2009 May;
11(1):31-40.
PMID: 19413707
This study is to update the estimates of the economic burden of illness because of overweight and obesity in Canada by incorporating the increase in prevalence of overweight and obesity,...
5.
Sizto S, Bansback N, Feldman S, Willian M, Anis A
Br J Dermatol
. 2009 Jan;
160(6):1264-72.
PMID: 19120346
Background: New biologics have dramatically changed therapeutic options for psoriasis, albeit at additional cost. Objectives: To determine the cost-effectiveness and optimal treatment sequence for moderate to severe psoriasis. Methods: Psoriasis...
6.
Marra C, Marion S, Guh D, Najafzadeh M, Wolfe F, Esdaile J, et al.
J Clin Epidemiol
. 2007 May;
60(6):616-24.
PMID: 17493521
Background: There is evidence that utility elicitation methods used in the calculation of quality-adjusted life years (QALYs) yield different results. It is not clear how these differences impact economic evaluations....
7.
Nosyk B, Li X, Sun H, Anis A
AIDS Care
. 2007 Apr;
19(4):546-53.
PMID: 17453596
The purpose of this study was to determine the effect of homelessness on the costs and patterns of hospitalisation in patients with HIV/AIDS. A retrospective longitudinal study design, based on...
8.
Anis A, Guh D, Hogg R, Wang X, Yip B, Craib K, et al.
Pharmacoeconomics
. 2004 Sep;
18(4):393-404.
PMID: 15344307
Objective: To estimate survival, the number of life-years gained and cost effectiveness of antiretroviral therapy (ART) regimens, denoted as ERA-I [zidovudine + (didanosine or zalcitabine)]; ERA-II [stavudine + (didanosine or...
9.
Marra C, Lynd L, Esdaile J, Kopec J, Anis A
Rheumatology (Oxford)
. 2004 Aug;
43(11):1390-7.
PMID: 15292531
Objective: Self-rated health (SRH) is an independent, strong predictor of morbidity and mortality. Socio-economic status (SES) is strongly associated with SRH. This study investigated the relationship between SES and SRH...
10.
Oh K, Anis A, Bae S
Rheumatology (Oxford)
. 2003 Aug;
43(2):156-63.
PMID: 12923290
Objectives: To evaluate the value of genotype-based dosing by polymerase chain reaction (PCR)-based polymorphism screening in terms of cost-effectiveness for treatment with azathioprine in Korea. Methods: Decision analysis was employed...